Jackson Financial Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Results of Operations
The following table sets forth, for the periods presented, certain data from our Consolidated Income Statements. The information contained in the table below should be read in conjunction with our Consolidated Financial Statements and the related notes elsewhere in this Form 10-K:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (in millions) | |||
| Revenues | |||
| Fee income | $7,983 | $8,083 | $7,680 |
| Premiums | 149 | 146 | 147 |
| Net investment income: | |||
| Net investment income excluding funds withheld assets | 2,296 | 1,838 | 1,680 |
| Net investment income on funds withheld assets | 855 | 1,024 | 1,174 |
| Total net investment income | 3,151 | 2,862 | 2,854 |
| Net gains (losses) on derivatives and investments: | |||
| Net gains (losses) on derivatives and investments | (3,357) | (6,812) | (5,864) |
| Net gains (losses) on funds withheld reinsurance treaties | (1,304) | (1,052) | (1,801) |
| Total net gains (losses) on derivatives and investments | (4,661) | (7,864) | (7,665) |
| Other income | 61 | 44 | 67 |
| Total revenues | 6,683 | 3,271 | 3,083 |
| Benefits and Expenses | |||
| Death, other policy benefits and change in policy reserves, net of deferrals | 927 | 868 | 965 |
| (Gain) loss from updating future policy benefits cash flow assumptions, net | 44 | 46 | 102 |
| Market risk benefits (gains) losses, net | 605 | (3,809) | (3,897) |
| Interest credited on other contract holder funds, net of deferrals and amortization | 1,221 | 1,110 | 1,145 |
| Interest expense | 100 | 101 | 109 |
| Operating costs and other expenses, net of deferrals | 2,797 | 2,825 | 2,549 |
| Amortization of deferred acquisition costs | 1,103 | 1,108 | 1,152 |
| Total benefits and expenses | 6,797 | 2,249 | 2,125 |
| Pretax income (loss) | (114) | 1,022 | 958 |
| Income tax expense (benefit) | (186) | 46 | 4 |
| Net income (loss) | 72 | 976 | 954 |
| Less: Net income (loss) attributable to noncontrolling interests | 45 | 30 | 20 |
| Net income (loss) attributable to Jackson Financial Inc. | 27 | 946 | 934 |
| Less: Dividends on preferred stock | 44 | 44 | 35 |
| Net income (loss) attributable to Jackson Financial Inc. common shareholders | $(17) | $902 | $899 |
Pretax Income (Loss)
Our pretax income (loss) decreased by $1,136 million to a pretax loss of $(114) million for the year ended December 31, 2025, from pretax income of $1,022 million for the year ended December 31, 2024, primarily due to:
$4,414 million unfavorable movements in market risk benefits (gains) losses, net, primarily due to less favorable movements in interest rates and unfavorable movements in equity volatility in 2025, compared to the prior year;
$111 million increase in interest credited on contract holder funds, net of deferrals and amortization, primarily due to higher average institutional account balances in 2025 and increased retail new business, compared to the prior year;
$100 million decrease in fee income primarily due to decreases in benefit-based guarantee fee income during 2025, and decreases in variable fee income driven by market volatility in the first half of 2025, which was partially offset by increase in separate account values in the second half of the year;
$57 million increase in death, other policy benefits, and change in policy reserves, net of (gain) loss from updating future policy benefits cash flow assumptions, primarily due to changes in mortality and higher other policyholder benefits, partially offset by the impact of actuarial assumption updates. See "Policy and Contract Liabilities" below for further information regarding our actuarial assumption updates.
These movements were partially offset by:
$3,203 million improvement in total net gains (losses) on derivatives and investments as discussed below:
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | Variance | |
| (in millions) | |||
| Net gains (losses) excluding derivatives and funds withheld assets | $(116) | $(11) | $(105) |
| Net gains (losses) on freestanding derivatives | (1,184) | (5,817) | 4,633 |
| Net gains (losses) on embedded derivatives (excluding funds withheld reinsurance) | (2,057) | (984) | (1,073) |
| Net gains (losses) on derivative instruments | (3,241) | (6,801) | 3,560 |
| Net gains (losses) on funds withheld reinsurance | (1,304) | (1,052) | (252) |
| Total net gains (losses) on derivatives and investments | $(4,661) | $(7,864) | $3,203 |
Volumes of freestanding derivatives can vary significantly period over period and movements in those derivatives are subject to interest rate or market movements. The movements in interest rate hedges during 2025 were primarily driven by a decrease in interest rates in the current year compared to an increase in interest rates in the prior year. The movements in equity hedges during 2025 were primarily driven by smaller increases in equity markets in the current year compared to larger increases in equity markets during 2024; and
Embedded derivative movements were unfavorable largely due to equity market increase impacts on our growing RILA block during 2025, compared to the prior year.
$289 million increase in net investment income as a result of higher income on bonds, lower expenses, and higher income on limited partnerships, which are recorded on a one quarter lag, partially offset by lower income on funds withheld assets during 2025; and
$28 million decrease in operating costs and other expenses, net of deferrals, primarily due to lower incentive and deferred compensation expenses during 2025, partially offset by higher other commissions expenses, net of deferrals, driven by higher retail sales, compared to prior year.
Income Taxes
Income tax expense (benefit) decreased $232 million to a benefit of $186 million for the year ended December 31, 2025, from an expense of $46 million for the year ended December 31, 2024.
The provision for income tax in the current period led to an effective tax rate ("ETR") of 117% for the year ended December 31, 2025, compared to an ETR of 5% for the year ended December 31, 2024. The year-over-year change in the ETR was due to the relationship of the taxable income to the consolidated pre-tax income (loss), the valuation allowance expense in the current year compared to a prior year benefit, and the interest benefit on IRS refund claims. The ETR differs from the statutory rate of 21% primarily due to the dividends received deduction, utilization of foreign tax credits, valuation allowance and the interest benefit on IRS refund claims.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.